| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Exelixis, Inc. (EXEL) has 10 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. EXEL is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.96M | $100.87M | - | |
| Dir | 1.55M | $79.74M | - | |
| Dir | 1.19M | $61.05M | - | |
| CFO | 1.12M | $57.36M | - | |
| VP | 594.7K | $30.53M | -43,451 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 29, 2020 | Morrissey Michael | President And CEO | Sale+OE | 25,000 | $17.87 | $446,750.00 | -22.5% | |
| Jan 23, 2020 | Morrissey Michael | President And CEO | Sale+OE | 25,000 | $19.41 | $485,250.00 | -22.5% | |
| Jan 22, 2020 | Scangos George A77 | Director | Sell | 25,000 | $19.75 | $493,750.00 | -2.4% | |
| Jan 16, 2020 | Morrissey Michael | President And CEO | Sale+OE | 25,000 | $20.33 | $508,250.00 | -22.5% | |
| Jan 15, 2020 | Scangos George A77 | Director | Sell | 25,000 | $20.39 | $509,750.00 | -2.3% | |
| Jan 15, 2020 | Marchesi Vincent T | Director | Sell | 61,683 | $20.01 | $1,234,276.83 | -42.8% | |
| Jan 8, 2020 | Morrissey Michael | President And CEO | Sale+OE | 25,000 | $18.85 | $471,250.00 | -22.5% | |
| Jan 7, 2020 | Schwab Gisela67 | Pres, Prod Dev &Med Aff &CMO | Sale+OE | 50,000 | $17.96 | $898,000.00 | -13.3% | |
| Jan 7, 2020 | Garber Alan M50 | Director | Sale+OE | 86,956 | $18.01 | $1,566,077.56 | -58.6% | |
| Jan 2, 2020 | Morrissey Michael | President And CEO | Sale+OE | 25,000 | $17.49 | $437,250.00 | -22.5% |